Integrated Diagnostics Holdings (LSE:IDHC) Tariff Resilience Score: 0/10 (As of Jul. 05, 2026)


LSE:IDHC Integrated Diagnostics Holdings PLC LSE:IDHC
59 GF Score
Price $0.50
GF Value $0.59
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Integrated Diagnostics Holdings Tariff Resilience Score?

Integrated Diagnostics Holdings has the Tariff Resilience Score of 0, which implies that the company might have .

Integrated Diagnostics Holdings has Healthcare diagnostics with operations in the Middle East and Africa. Some exposure to tariffs on medical equipment imports. Historical impacts have been limited. Mitigation through regional diversification and alternative suppliers. Industry-specific exemptions may apply.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Integrated Diagnostics Holdings might have .

Integrated Diagnostics Holdings  (LSE:IDHC) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Integrated Diagnostics Holdings Tariff Resilience Score Related Terms

LSE:IDHC
59GF Score
Integrated Diagnostics Holdings PLC LSE:IDHC
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Integrated Diagnostics Holdings (LSE:IDHC) Overvalued in 2026?

Based on GuruFocus' analysis, Integrated Diagnostics Holdings stock appears to be undervalued. The current stock price of $0.50 is trading 14.9% below its estimated GF Value™ of $0.59. GuruFocus considers Integrated Diagnostics Holdings to be Modestly Undervalued.

Key valuation signals for LSE:IDHC:

  • Tariff Resilience Score: 0
  • GF Value™: $0.59 vs. price of $0.50 (14.9% below fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the LSE:IDHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Integrated Diagnostics Holdings Business Description

Address 12 Castle Street, St Helier, JEY, JE2 3RT
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria, and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments: the Contract Segment, which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.
59GF Score

Get the complete analysis for LSE:IDHC

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.50
Price
$0.59
GF Value